Search Results - "Cheung, Lawrence H."
-
1
Production of Recombinant Gelonin Using an Automated Liquid Chromatography System
Published in Toxins (13-08-2020)“…Advances in recombinant DNA technology have opened up new possibilities of exploiting toxic proteins for therapeutic purposes. Bringing forth these protein…”
Get full text
Journal Article -
2
Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B
Published in Journal of experimental & clinical cancer research (30-07-2019)“…Immunotherapeutic approaches designed to augment T and B cell mediated killing of tumor cells has met with clinical success in recent years suggesting…”
Get full text
Journal Article -
3
Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells
Published in Molecular cancer therapeutics (01-07-2011)“…TNF-like weak inducer of apoptosis (TWEAK) and fibroblast growth factor (FGF)-inducible 14 (Fn14) are a TNF superfamily ligand-receptor pair involved in many…”
Get full text
Journal Article -
4
Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors
Published in Cancer research (Chicago, Ill.) (15-07-2013)“…The TNF-like weak inducer of apoptosis (TWEAK; TNFSF12) receptor Fn14 (TNFRSF12A) is expressed at low levels in normal tissues but frequently highly expressed…”
Get full text
Journal Article -
5
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B
Published in Journal for immunotherapy of cancer (01-09-2020)“…Antibody-drug conjugates are an exceptional and useful therapeutic tool for multiple diseases, particularly for cancer treatment. We previously showed that the…”
Get full text
Journal Article -
6
Construction and Characterization of Novel, Recombinant Immunotoxins Targeting the Her2/neu Oncogene Product: In vitro and In vivo Studies
Published in Cancer research (Chicago, Ill.) (01-12-2009)“…The goal of this study was to characterize a series of anti-Her2/neu immunotoxin constructs to identify how different antibodies and linker choices affect the…”
Get full text
Journal Article -
7
Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel
Published in PloS one (19-08-2009)“…There is a need for drug delivery systems (DDS) that can enhance cytosolic delivery of anti-cancer drugs trapped in the endo-lysosomal compartments. Exposure…”
Get full text
Journal Article -
8
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors
Published in Molecular cancer therapeutics (01-07-2009)“…Using gene expression profiling, others and we have recently found that claudin-3 ( CLDN3 ) and claudin-4 ( CLDN4 ) are two of the most highly and consistently…”
Get full text
Journal Article -
9
The rGel/BLyS Fusion Toxin Inhibits Diffuse Large B-cell Lymphoma Growth In Vitro and In Vivo
Published in Neoplasia (New York, N.Y.) (01-05-2010)“…Diffuse large B-cell lymphoma (DLBCL) is an aggressive subtype of B-cell non-Hodgkin lymphoma (NHL) and accounts for 30%to 40%of NHL. Molecules targeting…”
Get full text
Journal Article -
10
Antitumor activity of fibroblast growth factor receptor 3–specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis
Published in Molecular cancer therapeutics (01-04-2008)“…Human single-chain Fv directed against fibroblast growth factor receptor 3 (FGFR3) have been shown to block proliferation of RT112 bladder carcinoma cells in…”
Get full text
Journal Article -
11
Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2
Published in BMC cancer (17-08-2011)“…Abstract Background: The fusion protein VEGF121 /rGel composed of the growth factor VEGF121 and the plant toxin gelonin targets the tumor neovasculature and…”
Get full text
Journal Article -
12
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2
Published in Molecular cell (18-02-2016)“…Altered energy metabolism is a cancer hallmark as malignant cells tailor their metabolic pathways to meet their energy requirements. Glucose and glutamine are…”
Get full text
Journal Article -
13
The Antimelanoma Immunocytokine scFvMEL/TNF Shows Reduced Toxicity and Potent Antitumor Activity against Human Tumor Xenografts
Published in Neoplasia (New York, N.Y.) (01-05-2006)“…The immunocytokine scFvMEL/TNF, a fusion protein composed of human tumor necrosis factor (TNF) and a single-chain Fv antibody (scFv) scFvMEL targeting the…”
Get full text
Journal Article -
14
Targeted Apoptosis Activation with GrB/scFvMEL Modulates Melanoma Growth, Metastatic Spread, Chemosensitivity, and Radiosensitivity
Published in Neoplasia (New York, N.Y.) (01-02-2006)“…GrB/scFvMEL, a fusion protein composed of human granzyme B (GrB) and the single-chain antibody scFvMEL, targets melanoma gp240 antigen and exerts impressive…”
Get full text
Journal Article -
15
Characterization and Mechanistic Studies of a Novel Melanoma-Targeting Construct Containing IκBa for Specific Inhibition of Nuclear Factor-κB Activity
Published in Neoplasia (New York, N.Y.) (01-10-2010)“…The transcription factor nuclear factor-κB (NF-κB) is a central mediator of growth and homeostasis for both normal and neoplastic cells. IκBα is the natural…”
Get full text
Journal Article -
16
Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy
Published in Journal of controlled release (28-10-2018)“…Interactions between stromal cells and tumor cells pay a major role in cancer growth and progression. This is reflected in the composition of anticancer drugs…”
Get full text
Journal Article -
17
Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents
Published in Molecular cancer therapeutics (01-12-2003)“…The serine protease granzyme B (GrB, 25 kDa) can initiate apoptosis by multiple mechanisms including directly activating caspases, inducing DNA fragmentation,…”
Get full text
Journal Article -
18
A novel in vivo model using immunotoxin in the absence of p-glycoprotein to achieve ultra selective depletion of target cells: Applications in trogocytosis and beyond
Published in Journal of immunological methods (01-08-2020)“…A commonly employed method to determine the function of a particular cell population and to assess its contribution to the overall system in vivo is to…”
Get full text
Journal Article -
19
Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF(121)/rGel fusion toxin
Published in Journal of controlled release (28-04-2014)“…Vascular targeting for cancer is increasingly recognized as a therapeutic strategy although the lack of objective responses and the development of resistance…”
Get full text
Journal Article -
20
Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization
Published in Journal of clinical medicine (26-12-2019)“…The objective of this study was to develop and explore a novel CD133-targeting immunotoxin (IT) for use in combination with the endosomal escape method…”
Get full text
Journal Article